Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA045617 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA045617, RRID:AB_2679391
- Product name
- Anti-CSRP2
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human CSRP2, Gene description: cysteine and glycine-rich protein 2, Alternative Gene Names: CRP2, LMO5, SmLIM, Validated applications: IHC, Uniprot ID: Q16527, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.05 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Significance of the p38MAPK-CRP2 axis in myofibroblastic phenotypic transition
Role of CRP2-MRTF interaction in functions of myofibroblasts
CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways
Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2
CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis
Hayashi K, Labios R, Morita T, Ashimori A, Aoki R, Mikuni M, Kimura K
Cell Structure and Function 2023;48(2):199-210
Cell Structure and Function 2023;48(2):199-210
Role of CRP2-MRTF interaction in functions of myofibroblasts
Hayashi K, Horoiwa S, Mori K, Miyata H, Labios R, Morita T, Kobayashi Y, Yamashiro C, Higashijima F, Yoshimoto T, Kimura K, Nakagawa Y
Cell Structure and Function 2023;48(1):83-98
Cell Structure and Function 2023;48(1):83-98
CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways
Chen L, Long X, Duan S, Liu X, Chen J, Lan J, Liu X, Huang W, Geng J, Zhou J
Theranostics 2020;10(24):11063-11079
Theranostics 2020;10(24):11063-11079
Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2
Hoffmann C, Mao X, Brown-Clay J, Moreau F, Al Absi A, Wurzer H, Sousa B, Schmitt F, Berchem G, Janji B, Thomas C
Scientific Reports 2018;8(1)
Scientific Reports 2018;8(1)
CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis
Hoffmann C, Mao X, Dieterle M, Moreau F, Al Absi A, Steinmetz A, Oudin A, Berchem G, Janji B, Thomas C
Oncotarget 2016;7(12):13688-13705
Oncotarget 2016;7(12):13688-13705
No comments: Submit comment
No validations: Submit validation data